Birich Technologies Overview

  • Founded
  • 2011

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Birich Technologies General Information


Developer of gene-silencing technology designed to detect diseases. The company's gene-silencing technology offers a proprietary protein delivery technology for RNAI, enabling doctors to detect and treat gene related diseases.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Drug Delivery
Other Industries
Primary Office
  • 301 West Preston Street
  • Room 801
  • Baltimore, MD 21201
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Birich Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Nov-2016 00000 Completed Out of Business
2. Grant 26-Feb-2014 00000 00000 Completed Startup
1. Accelerator/Incubator 20-Feb-2013 $149K $149K Completed Startup
To view Birich Technologies’s complete valuation and funding history, request access »

Birich Technologies Executive Team (3)

Name Title Board Seat Contact Info
Vivek Advani Acting Chief Technology Officer
Chanda Arya Ph.D Co-Founder & President
You’re viewing 2 of 3 executive team members. Get the full list »